Back

Specific MMP-9 and MMP-2 inhibition by novel MMP antibody attenuates LV remodeling secondary to volume overload

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Cardiac remodelling Drugs, Drug Targets ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mrs Lena Cohen

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)

9 More presentations in this session

Presentation thumbnail
SLMAP expression is altered during cardiac remodeling and it regulates cardiomyocyte response to adrenergic stimuli
Associate Professor M. Nader (Riyadh, SA)
Abstract
Presentation thumbnail
Anti-inflammatory factor Del-1 protects from angiotensin II-induced hypertension and cardiovascular remodelling
Doctor I. Kopaliani (Dresden, DE)
Abstract
Presentation thumbnail
Cardiac nuclear high-mobility group box 1 attenuates angiotensin II induced pathological cardiac hypertrophy by inhibiting DNA damage response pathway
Doctor T. Takahashi (Yamagata, JP)
Abstract
Presentation thumbnail
Loss of akap1 exacerbates pressure overload-induced cardiac hypertrophy and failure
Mr N. Boccella (Napoly, IT)
Abstract
Presentation thumbnail
Teneligliptin attenuated AngII-induced cardiac hypertrophy by inhibiting Nox4-HDAC4 axis
Mr K. Okabe (Fukuoka, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Cardiac remodelling

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources